Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Plasmacytoma × Dexamethasone × Clear all

Phase

Status

Completed 5 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 109 Recurrence 17 Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Neoplasms, Plasma Cell 12 Burkitt Lymphoma 8 Neoplasms 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Neoplasm Metastasis 4 Immunoglobulin Light-chain Amyloidosis 4 Smoldering Multiple Myeloma 3 Prostatic Neoplasms 3 Rectal Neoplasms 2 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2 Paraproteinemias 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Fatigue 2 Brain Neoplasms 2 Wrist Fractures 1 Uterine Cervical Neoplasms 1 Plasmacytoma 1 Pancreatic Neoplasms 1 Pain 1 Oropharyngeal Neoplasms 1 Neurotoxicity Syndromes 1 Neoplasm, Residual 1 Nausea 1

Interventions

Lenalidomide 2 cc-486 1 Radiotherapy 1 Dexamethasone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02544308 2022-12-23

IDRIS

University College, London

Phase 3 Active not recruiting

Plasmacytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡